Ignite Creation Date:
2025-12-24 @ 10:00 PM
Ignite Modification Date:
2026-01-04 @ 6:52 PM
Study NCT ID:
NCT02538432
Status:
WITHDRAWN
Last Update Posted:
2019-11-04
First Post:
2015-08-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors
Sponsor:
University of Maryland, Baltimore
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2019-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-12
Completion Date Type:
ESTIMATED
First Submit Date:
2015-08-31
First Submit QC Date:
None
Study First Post Date:
2015-09-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-31
Last Update Post Date:
2019-11-04
Last Update Post Date Type:
ACTUAL